nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenylephrine—Intraocular pressure increased—Hydrochlorothiazide—nephrolithiasis	0.0764	0.11	CcSEcCtD
Phenylephrine—Epigastric pain—Hydrochlorothiazide—nephrolithiasis	0.0696	0.1	CcSEcCtD
Phenylephrine—Ventricular arrhythmia—Hydrochlorothiazide—nephrolithiasis	0.0454	0.0655	CcSEcCtD
Phenylephrine—Stinging—Hydrochlorothiazide—nephrolithiasis	0.0415	0.0598	CcSEcCtD
Phenylephrine—ADRA1A—Endothelin Pathways—ADCY10—nephrolithiasis	0.0303	0.0989	CbGpPWpGaD
Phenylephrine—Pulmonary oedema—Hydrochlorothiazide—nephrolithiasis	0.0299	0.0431	CcSEcCtD
Phenylephrine—Visual disturbance—Hydrochlorothiazide—nephrolithiasis	0.0257	0.0371	CcSEcCtD
Phenylephrine—Orthostatic hypotension—Hydrochlorothiazide—nephrolithiasis	0.0223	0.0321	CcSEcCtD
Phenylephrine—Abdominal pain upper—Hydrochlorothiazide—nephrolithiasis	0.0223	0.0321	CcSEcCtD
Phenylephrine—Acute coronary syndrome—Hydrochlorothiazide—nephrolithiasis	0.0185	0.0267	CcSEcCtD
Phenylephrine—Myocardial infarction—Hydrochlorothiazide—nephrolithiasis	0.0184	0.0266	CcSEcCtD
Phenylephrine—Bradycardia—Hydrochlorothiazide—nephrolithiasis	0.0172	0.0248	CcSEcCtD
Phenylephrine—ADRA1D—Monoamine GPCRs—CHRM3—nephrolithiasis	0.0171	0.0557	CbGpPWpGaD
Phenylephrine—Visual impairment—Hydrochlorothiazide—nephrolithiasis	0.0163	0.0235	CcSEcCtD
Phenylephrine—Arrhythmia—Hydrochlorothiazide—nephrolithiasis	0.0151	0.0217	CcSEcCtD
Phenylephrine—Tension—Hydrochlorothiazide—nephrolithiasis	0.0144	0.0208	CcSEcCtD
Phenylephrine—Dysgeusia—Hydrochlorothiazide—nephrolithiasis	0.0144	0.0208	CcSEcCtD
Phenylephrine—ADRA1D—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.0144	0.0468	CbGpPWpGaD
Phenylephrine—Nervousness—Hydrochlorothiazide—nephrolithiasis	0.0143	0.0206	CcSEcCtD
Phenylephrine—ADRA1B—Monoamine GPCRs—CHRM3—nephrolithiasis	0.0142	0.0462	CbGpPWpGaD
Phenylephrine—Vision blurred—Hydrochlorothiazide—nephrolithiasis	0.0138	0.02	CcSEcCtD
Phenylephrine—Tremor—Hydrochlorothiazide—nephrolithiasis	0.0138	0.0199	CcSEcCtD
Phenylephrine—Agitation—Hydrochlorothiazide—nephrolithiasis	0.0135	0.0195	CcSEcCtD
Phenylephrine—Syncope—Hydrochlorothiazide—nephrolithiasis	0.0132	0.019	CcSEcCtD
Phenylephrine—Palpitations—Hydrochlorothiazide—nephrolithiasis	0.013	0.0187	CcSEcCtD
Phenylephrine—Loss of consciousness—Hydrochlorothiazide—nephrolithiasis	0.0129	0.0186	CcSEcCtD
Phenylephrine—ADRA1A—Monoamine GPCRs—CHRM3—nephrolithiasis	0.0126	0.0411	CbGpPWpGaD
Phenylephrine—Chest pain—Hydrochlorothiazide—nephrolithiasis	0.0125	0.018	CcSEcCtD
Phenylephrine—ADRA1B—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.0119	0.0389	CbGpPWpGaD
Phenylephrine—Shock—Hydrochlorothiazide—nephrolithiasis	0.0118	0.017	CcSEcCtD
Phenylephrine—Tachycardia—Hydrochlorothiazide—nephrolithiasis	0.0117	0.0169	CcSEcCtD
Phenylephrine—Hyperhidrosis—Hydrochlorothiazide—nephrolithiasis	0.0116	0.0167	CcSEcCtD
Phenylephrine—Paraesthesia—Hydrochlorothiazide—nephrolithiasis	0.0108	0.0155	CcSEcCtD
Phenylephrine—Dyspnoea—Hydrochlorothiazide—nephrolithiasis	0.0107	0.0154	CcSEcCtD
Phenylephrine—ADRA1A—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.0106	0.0345	CbGpPWpGaD
Phenylephrine—ADRA1D—Calcium Regulation in the Cardiac Cell—RGS14—nephrolithiasis	0.0105	0.0341	CbGpPWpGaD
Phenylephrine—Pain—Hydrochlorothiazide—nephrolithiasis	0.0103	0.0148	CcSEcCtD
Phenylephrine—Urticaria—Hydrochlorothiazide—nephrolithiasis	0.00953	0.0137	CcSEcCtD
Phenylephrine—Hypersensitivity—Hydrochlorothiazide—nephrolithiasis	0.00884	0.0127	CcSEcCtD
Phenylephrine—ADRA1B—Calcium Regulation in the Cardiac Cell—RGS14—nephrolithiasis	0.00869	0.0283	CbGpPWpGaD
Phenylephrine—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.00848	0.0122	CcSEcCtD
Phenylephrine—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.00793	0.0114	CcSEcCtD
Phenylephrine—ADRA1A—Calcium Regulation in the Cardiac Cell—RGS14—nephrolithiasis	0.00772	0.0252	CbGpPWpGaD
Phenylephrine—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.00763	0.011	CcSEcCtD
Phenylephrine—ADRA1D—GPCRs, Other—CHRM3—nephrolithiasis	0.00758	0.0247	CbGpPWpGaD
Phenylephrine—Rash—Hydrochlorothiazide—nephrolithiasis	0.00756	0.0109	CcSEcCtD
Phenylephrine—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.00755	0.0109	CcSEcCtD
Phenylephrine—Headache—Hydrochlorothiazide—nephrolithiasis	0.00751	0.0108	CcSEcCtD
Phenylephrine—MAOA—Biological oxidations—SLC26A1—nephrolithiasis	0.00725	0.0237	CbGpPWpGaD
Phenylephrine—Nausea—Hydrochlorothiazide—nephrolithiasis	0.00712	0.0103	CcSEcCtD
Phenylephrine—ADRA1D—G alpha (q) signalling events—DGKH—nephrolithiasis	0.0059	0.0192	CbGpPWpGaD
Phenylephrine—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—DGKH—nephrolithiasis	0.00527	0.0172	CbGpPWpGaD
Phenylephrine—ADRA1D—Calcium Regulation in the Cardiac Cell—CHRM3—nephrolithiasis	0.00511	0.0167	CbGpPWpGaD
Phenylephrine—ADRA1B—G alpha (q) signalling events—DGKH—nephrolithiasis	0.00489	0.016	CbGpPWpGaD
Phenylephrine—CYP1A2—Phase II conjugation—SLC26A1—nephrolithiasis	0.00457	0.0149	CbGpPWpGaD
Phenylephrine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—DGKH—nephrolithiasis	0.00438	0.0143	CbGpPWpGaD
Phenylephrine—ADRA1A—G alpha (q) signalling events—DGKH—nephrolithiasis	0.00435	0.0142	CbGpPWpGaD
Phenylephrine—ADRA1D—G alpha (q) signalling events—CHRM3—nephrolithiasis	0.00426	0.0139	CbGpPWpGaD
Phenylephrine—ADRA1B—Calcium Regulation in the Cardiac Cell—CHRM3—nephrolithiasis	0.00424	0.0138	CbGpPWpGaD
Phenylephrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—DGKH—nephrolithiasis	0.00389	0.0127	CbGpPWpGaD
Phenylephrine—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—CHRM3—nephrolithiasis	0.00381	0.0124	CbGpPWpGaD
Phenylephrine—ADRA1A—Calcium Regulation in the Cardiac Cell—CHRM3—nephrolithiasis	0.00377	0.0123	CbGpPWpGaD
Phenylephrine—ADRA1B—G alpha (q) signalling events—CHRM3—nephrolithiasis	0.00354	0.0115	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.0033	0.0107	CbGpPWpGaD
Phenylephrine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—CHRM3—nephrolithiasis	0.00316	0.0103	CbGpPWpGaD
Phenylephrine—ADRA1A—G alpha (q) signalling events—CHRM3—nephrolithiasis	0.00314	0.0103	CbGpPWpGaD
Phenylephrine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.00282	0.00921	CbGpPWpGaD
Phenylephrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—CHRM3—nephrolithiasis	0.00281	0.00917	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.00274	0.00892	CbGpPWpGaD
Phenylephrine—CYP1A2—Biological oxidations—SLC26A1—nephrolithiasis	0.00267	0.00872	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR downstream signaling—RGS14—nephrolithiasis	0.00249	0.00811	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.00243	0.00792	CbGpPWpGaD
Phenylephrine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.00234	0.00764	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—RGS14—nephrolithiasis	0.00226	0.00737	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR ligand binding—CHRM3—nephrolithiasis	0.00215	0.00701	CbGpPWpGaD
Phenylephrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.00208	0.00679	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR downstream signaling—RGS14—nephrolithiasis	0.00206	0.00673	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR ligand binding—PTH—nephrolithiasis	0.00197	0.00641	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—RGS14—nephrolithiasis	0.00188	0.00612	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR downstream signaling—RGS14—nephrolithiasis	0.00183	0.00598	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR ligand binding—CHRM3—nephrolithiasis	0.00178	0.00582	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR downstream signaling—DGKH—nephrolithiasis	0.00168	0.00548	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—RGS14—nephrolithiasis	0.00167	0.00543	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—GRHPR—nephrolithiasis	0.00164	0.00534	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR ligand binding—PTH—nephrolithiasis	0.00163	0.00532	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR ligand binding—CHRM3—nephrolithiasis	0.00158	0.00517	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—ADCY10—nephrolithiasis	0.00157	0.00512	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—DGKH—nephrolithiasis	0.00153	0.00498	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—AGXT—nephrolithiasis	0.00146	0.00476	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR ligand binding—PTH—nephrolithiasis	0.00145	0.00473	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR downstream signaling—DGKH—nephrolithiasis	0.00139	0.00455	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—RGS14—nephrolithiasis	0.00133	0.00435	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—ADCY10—nephrolithiasis	0.0013	0.00425	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—DGKH—nephrolithiasis	0.00127	0.00413	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—SLC26A1—nephrolithiasis	0.00124	0.00404	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—APRT—nephrolithiasis	0.00124	0.00404	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR downstream signaling—DGKH—nephrolithiasis	0.00124	0.00404	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR downstream signaling—CHRM3—nephrolithiasis	0.00121	0.00396	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—ADCY10—nephrolithiasis	0.00116	0.00377	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—DGKH—nephrolithiasis	0.00113	0.00367	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR downstream signaling—PTH—nephrolithiasis	0.00111	0.00362	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—RGS14—nephrolithiasis	0.00111	0.00361	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—CHRM3—nephrolithiasis	0.0011	0.0036	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—PTH—nephrolithiasis	0.00101	0.00329	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR downstream signaling—CHRM3—nephrolithiasis	0.00101	0.00329	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—RGS14—nephrolithiasis	0.000984	0.00321	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR downstream signaling—PTH—nephrolithiasis	0.000922	0.00301	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—CHRM3—nephrolithiasis	0.000916	0.00299	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000901	0.00294	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—DGKH—nephrolithiasis	0.000901	0.00294	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000896	0.00292	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—AQP1—nephrolithiasis	0.000884	0.00288	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—PTH—nephrolithiasis	0.000838	0.00273	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR downstream signaling—PTH—nephrolithiasis	0.000819	0.00267	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—CHRM3—nephrolithiasis	0.000813	0.00265	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—CHRM3—nephrolithiasis	0.000799	0.00261	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—DGKH—nephrolithiasis	0.000748	0.00244	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000748	0.00244	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—PTH—nephrolithiasis	0.000744	0.00243	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000665	0.00217	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—DGKH—nephrolithiasis	0.000665	0.00217	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—CHRM3—nephrolithiasis	0.000652	0.00213	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—GRHPR—nephrolithiasis	0.000604	0.00197	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—PTH—nephrolithiasis	0.000596	0.00194	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—CHRM3—nephrolithiasis	0.000541	0.00176	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—AGXT—nephrolithiasis	0.000538	0.00175	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—PTH—nephrolithiasis	0.000495	0.00161	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—CHRM3—nephrolithiasis	0.000481	0.00157	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—SLC26A1—nephrolithiasis	0.000457	0.00149	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—APRT—nephrolithiasis	0.000457	0.00149	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—PTH—nephrolithiasis	0.000439	0.00143	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—AQP1—nephrolithiasis	0.000326	0.00106	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—SPP1—nephrolithiasis	0.000299	0.000976	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—CHRM3—nephrolithiasis	0.000295	0.000961	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—SPP1—nephrolithiasis	0.000248	0.00081	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—SPP1—nephrolithiasis	0.000221	0.00072	CbGpPWpGaD
